Recently, Conceptus (NasdaqGS:CPTS - News) received an Approvable Letter from the US Food and Drug Administration (:FDA). The letter suggests compatibility between the company’s surgical permanent ...
NovaSure patients in study also used fewer pads and tampons, reported better menstrual-related quality of life and alleviation of PMS symptoms as compared to Minerva patients The pivotal study ...
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, will launch the NovaSure® V5 global endometrial ablation (GEA) device at the American Association ...
Hologic’s NovaSure is a minimally invasive endometrial ablation system designed to treat abnormal uterine bleeding (:AUB). According to Hologic, unlike other endometrial ablation treatment techniques, ...
BEDFORD, Mass., May 11 Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical ...
MARLBOROUGH, Mass. — Hologic Inc. (Nasdaq: HOLX), a global leader in women’s health, has announced approval of the NovaSure ® V5 global endometrial ablation (GEA) device in Canada and Europe. This ...
Tanya Perry was looking for relief from heavy bleeding during her period when her ob/gyn suggested endometrial ablation with the NovaSure device in May 2017. Her doctor told her it would be a quick ...
BEDFORD, Massachusetts, Nov. 20, 2014 /PRNewswire/ -- Hologic, Inc. (NASDAQ: HOLX), today announced the launch of the next-generation NovaSure 6mm global endometrial ablation (GEA) system. The ...
Over the last 20 years, the NovaSure system has built a trusted legacy in GEA. The NovaSure device first received FDA approval in 2001, and by 2018 the NovaSure procedure had been used to treat over 3 ...
Hologic HOLX, a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, ...
“Since its launch over 20 years ago, we have constantly listened to our customers’ feedback, which has driven continuous design improvements for NovaSure,” said Jan Verstreken, Group President, ...
Hologic (NASDAQ:HOLX) said its V5 global endometrial ablation designed to treat a wide range of cervical and uterine anatomies had been approved in Canada and Europe. NovaSure V5 has a cervical seal, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback